Washington University Career Development Program in Drug Abuse and Addiction

华盛顿大学药物滥用和成瘾职业发展计划

• 批准号: 10657611
• 负责人: Laura J. Bierut
• 金额: $ 47.68万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-05-01 至 2027-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10657611
• 关键词: Address; Cause of Death; Communication; Communities; Complex; Development; Development Plans; Discipline; Drug Addiction; Drug abuse; Educational Curriculum; Equilibrium; Evaluation; Faculty; Fostering; Funding; Genetic; Goals; Individual; Interview; Life; Mentored Clinical Scientist Development Program; Mentors; Mentorship; Methodology; Monitor; National Institute of Drug Abuse; Positioning Attribute; Prevention; Program Development; Research; Research Personnel; Research Project Grants; Resource Sharing; Science; Scientist; Substance Use Disorder; Surveys; Technology; Training; Training Programs; Universities; Washington; Work; career; career development; clinical care; design; interdisciplinary approach; interest; medical schools; next generation; programs; resilience; substance use treatment; training opportunity

Abstract Substance use disorder is multifactorial with genetic and environmental contributions and this illness is a leading cause of death worldwide. Approaches from single disciplines have done much to advance science, and methodological and technological advances have established the need for increasingly multidisciplinary approaches to address complex questions about substance use disorder. Bringing this potential of scientific discovery to advance the prevention and treatment of substance use disorder requires clinician scientists who can bridge the gaps between scientific discovery and clinical care. The goal of the K12 program is to train the next generation of clinician scientists to fill these gaps and undertake this important and exciting work. To accomplish this goal, we have established three aims: 1. Expand the workforce of clinician scientists in the prevention and treatment of substance use disorder. We will fund two scholar faculty positions per year at Washington University School of Medicine. Using a scholar-centric approach, we will design a career development plan that will meet each scholar’s needs and interests. We will provide short-term and long-term mentorship through formal mentoring relationships with local and national faculty and advisors from multiple disciplines. New opportunities to aid the scholars include wellness and resilience support, career coaching, and guidance for work/life balance. We are committed to the training and retention of scholars from diverse backgrounds. 2. Continue to develop and enhance the K12 career development opportunities and continue robust evaluation and tracking of K12 scholars, faculty, mentors, curriculum, and training opportunities. We will enhance our current program by implementing online individual career development plans that can be monitored by scholars, mentors, and Program Directors. A Research Navigator will increase support of the scholars in managing and conducting their research projects. We will monitor and evaluate the scholars, mentors, faculty and training programs using surveys, interviews, and other metrics. 3. Establish a national network of NIDA K12 Program Directors and scholars. This national consortium will serve as an avenue of communication between Program Directors and scholars across all NIDA K12 programs, creating a community with common goals, with the intent to share resources, enhance networking, and foster the development of the next generation of researchers in substance use disorder. Successful completion of these aims will result in increased numbers of diverse, well-trained clinician scientists in the prevention and treatment of substance use disorder and its consequences.

抽象的 药物使用障碍是多因素的，具有遗传和环境贡献，这种疾病是一种 全球死亡的主要原因。来自单一学科的方法为推进科学做了很多事情， 方法论和技术进步已经确定了越来越多的多学科的需求 解决有关药物使用障碍的复杂问题的方法。带来科学的潜力 提高预防和治疗药物使用障碍的发现需要临床科学家 可以弥合科学发现与临床护理之间的差距。 K12程序的目标是训练 下一代临床科学家填补这些空白并进行这项重要而令人兴奋的工作。到 实现这一目标，我们确定了三个目标： 1。扩大临床科学家在预防和治疗物质使用方面的劳动力 紊乱。我们将在华盛顿大学医学院每年为两名学校教职员工提供资金。 使用以科学为中心的方法，我们将设计一项职业发展计划，以满足每种科学的 需求和兴趣。我们将通过形式上的心态提供短期和长期的心态 与地方和国家教师以及来自多个学科的顾问的关系。帮助的新机会 学者包括健康和韧性支持，职业教练以及工作/生活平衡指导。 我们致力于从潜水员背景的培训和保留学者。 2。继续发展和增强K12职业发展机会并继续强大 评估和跟踪K12学者，教师，导师，课程和培训机会。 我们将通过实施在线个人职业发展计划来增强我们当前的计划 由学者，导师和计划主管监视。研究导航器将增加对 管理和进行研究项目的学者。我们将监视和评估 使用调查，访谈和其他指标的学者，导师，教师和培训计划。 3。建立NIDA K12计划董事和学者的国家网络。这个国家财团 将作为所有NIDA K12的计划主管和学者之间的沟通途径 计划，创建一个具有共同目标的社区，意图共享资源，增强 网络，并促进下一代研究人员在药物使用障碍领域的发展。 这些目标的成功完成将导致潜水员数量增加，训练有素的临床科学家 在预防和治疗物质使用障碍及其后果方面。

项目成果

Mental Illness and Violence Among People Experiencing Homelessness: An Evidence-Based Review.

无家可归者的精神疾病和暴力：基于证据的审查。

• 发表时间: 2024
• 期刊: Missouri medicine
• 作者: Xu,KevinY;Gold,JessicaA;Szlyk,HannahS;Rolin,StephanieA;Shields,MorganC
• 通讯作者: Shields,MorganC

A Community-Engaged Approach to Understanding Suicide in a Small Rural County in Georgia: A Two-Phase Content Analysis of Individual and Focus Group Interviews.

• DOI: 10.3390/ijerph20247145
• 发表时间: 2023-12-05
• 期刊: International journal of environmental research and public health

Preferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis.

寻求阿片类药物使用障碍治疗的患者的药物偏好：联合分析。

• DOI: 10.1016/j.josat.2023.209138
• 发表时间: 2023
• 期刊: Journal of substance use and addiction treatment
• 作者: Muthulingam,Dharushana;Hassett,ThomasC;Madden,LynnM;Bromberg,DanielJ;Fraenkel,Liana;Altice,FrederickL
• 通讯作者: Altice,FrederickL

Screen Use and Social Media "Addiction" in the Era of TikTok: What Generalists Should Know.

TikTok 时代的屏幕使用和社交媒体“成瘾”：通才应该知道什么。

• 发表时间: 2023
• 期刊: Missouri medicine
• 作者: Xu,KevinY;Tedrick,Tiffany;Gold,JessicaA
• 通讯作者: Gold,JessicaA

Toward the implementation of genomic applications for smoking cessation and smoking-related diseases.

致力于实施戒烟和吸烟相关疾病的基因组应用。

• DOI: 10.1093/tbm/ibx060
• 发表时间: 2018
• 期刊: Translational behavioral medicine
• 影响因子: 3.6
• 作者: Ramsey,AlexT;Chen,Li-Shiun;Hartz,SarahM;Saccone,NancyL;Fisher,SherriL;Proctor,EnolaK;Bierut,LauraJ
• 通讯作者: Bierut,LauraJ